Condition: Psychiatric Adults Patients · Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
In the absence of easy access to second-line ambulatory care, the number of 'inappropriate' psychiatric emergency visits is increasing, with emergency departments becoming the gateway to mental health care. This is the context in which the 'med@psy' system was set up in the Toulon-Provence-Mediterranean metropolitan area by a private psychiatrist. It facilitates access to psychiatric second referral for General Practitioners (GPs) by pooling the 48-hour supply of psychiatric consultations in real time. It is assumed that this system will facilitate access to outpatient psychiatric care and help to optimize the organisation of patient care and follow-up. The aim of this study is to evaluate the med@psy system in the care pathway for patients with psychiatric disorders. This study main objective is to compare the proportion of patients with a psychiatric disorder who will receive outpatient follow-up 1 month after a visit to a psychiatric emergency department without hospitalization (Group 1) versus 1 month after a consultation with a psychiatrist within 48 hours via the med@psy system (Group 2).
This description comes directly from the study's public registry record.
Asmaa Jobic · +33 4 83 77 20 61 · asmaa.jobic@ch-toulon.fr
Fabien Korrichi, MD · docteurkorrichifabien@gmail.com
Always discuss trial participation with your own doctor first.
| Cabinet médical Korrichi (Med@psy program linked to this office) | Toulon, Var, France | Recruiting |
| Centre Hospitalier Intercommunal Toulon La Seyne sur Mer emergency reception service | Toulon, Var, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06581874